T he optim al type and duration o f antifungal therapy for localized aspergillosis in cardiac transplant recipients is unclear. W e report the case o f a patient w ho had persistent invasive pulm onary asp ergillosis desp ite prolonged treatm ent w ith am photericin B. A com bined ap proach using antifungal therapy and surgery appears effective for localized pulm onary disease. A spergillar in fection in solid organ transplant recipients is reviewed. 
In summary, isolated pulmonary disease due to Aspergillus may be less aggressive in solid organ transplant recipients than in other immunocompromised patients. Our patient had persistent but controlled disease despite long-term, highdose amphotericin B therapy. In spite o f immunosuppressive therapy, his lesion continued to decrease in size with a weekly maintenance regimen o f amphotericin B after daily high-dose therapy brought about clinical and radiographic improvement. Despite administration o f a large total dose o f amphotericin, hyphae were present in the lesion removed at surgery, a fact suggesting that suppression occurred but not eradication. If a pulmonary lesion is too large to be resected, amphotericin B could be given until the lesion decreases in size. Although excisional surgery reportedly has been per formed in only a small number o f patients, it may be curative in patients such as ours and is worthy o f consideration.
